| RSVYX | VMVAX | RSVYX / VMVAX | |
| Total Expense Ratio | 1.06 | 0.07 | 1,514% |
| Annual Report Gross Expense Ratio | 1.07 | 0.07 | 1,529% |
| Fund Existence | 19 years | 15 years | - |
| Gain YTD | 10.859 | 15.500 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 258M | 37.2B | 1% |
| Annual Yield % from dividends | 0.72 | 1.81 | 40% |
| Returns for 1 year | 7.24 | 22.51 | 32% |
| Returns for 3 years | 7.56 | 44.10 | 17% |
| Returns for 5 years | -0.46 | 46.55 | -1% |
| Returns for 10 years | -1.71 | 127.98 | -1% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VZGRX | 60.67 | 0.98 | +1.64% |
| Virtus Zevenbergen Innovative Gr Stk R6 | |||
| HDGYX | 40.50 | 0.30 | +0.75% |
| Hartford Dividend and Growth Y | |||
| GPRIX | 14.76 | 0.08 | +0.54% |
| Grandeur Peak Global Reach Instl | |||
| BGEKX | 14.48 | -0.04 | -0.28% |
| Baillie Gifford International Growth K | |||
| NBHCX | 16.44 | -0.07 | -0.42% |
| Neuberger Equity Income C | |||